Importer of Controlled Substances Application: Agilent Technologies, 32422-32423 [2020-11546]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
32422
Federal Register / Vol. 85, No. 104 / Friday, May 29, 2020 / Notices
provide a report containing its advice as
to the probable economic effect of
providing duty-free treatment for
imports of currently dutiable products
from Kenya on (i) industries in the
United States producing like or directly
competitive products, and (ii)
consumers. The USTR asked that the
Commission’s analysis consider each
article in chapters 1 through 97 of the
Harmonized Tariff Schedule of the
United States (HTS) for which U.S.
tariffs will remain, taking into account
implementation of U.S. commitments in
the World Trade Organization. The
USTR asked that the advice be based on
the HTS in effect during 2020 and trade
data for 2019.
In addition, the USTR requested that
the Commission prepare an assessment,
as described in section
105(a)(2)(B)(i)(III) of the Bipartisan
Congressional Trade Priorities and
Accountability Act of 2015, of the
probable economic effects of eliminating
tariffs on imports from Kenya of those
agricultural products described in the
list attached to the USTR’s request letter
on (i) industries in the United States
producing the products concerned, and
(ii) the U.S. economy as a whole. The
USTR’s request letter and list of
agricultural products are posted on the
Commission’s website at https://
www.usitc.gov.
The Commission will provide its
report to the USTR by September 16,
2020, or as soon as possible. The USTR
indicated that those sections of the
Commission’s report that relate to the
advice and assessment of probable
economic effects will be classified. The
USTR also indicated that he considers
the Commission’s report to be an
interagency memorandum that will
contain pre-decisional advice and be
subject to the deliberative process
privilege.
Public Hearing: A public hearing in
connection with this investigation will
be held beginning at 9:30 a.m. on July
7, 2020, using Go To Meeting.
Information about the hearing, will be
posted on the Commission’s website at
(https://usitc.gov/research_and_
analysis/what_we_are_working_
on.htm). Once on that web page, scroll
down to the entry for Investigation No.
131–046, U.S.-Kenya Trade Agreement:
Advice on the Probable Economic Effect
of Providing Duty-free Treatment for
Currently Dutiable Imports, and click on
the link to ‘‘hearing instructions.’’
Requests to appear at the public hearing
should be filed with the Secretary no
later than 5:15 p.m., June 10, 2020, in
accordance with the requirements in the
‘‘Written Submissions’’ section below.
All prehearing briefs and statements
VerDate Sep<11>2014
17:06 May 28, 2020
Jkt 250001
should be filed not later than 5:15 p.m.,
June 12, 2020, and all post-hearing
briefs and statements should be filed not
later than 5:15 p.m., July 14, 2020. All
requests to appear, and pre- and posthearing briefs and statements should be
filed in accordance with the
requirements of the ‘‘written
submissions’’ section below.
Written Submissions: In lieu of or in
addition to participating in the hearing,
interested parties are invited to file
written submissions concerning this
investigation. All written submissions
should be addressed to the Secretary,
and should be received not later than
5:15 p.m., July 14, 2020. All written
submissions must conform to the
provisions of section 201.8 of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.8), as
temporarily amended by 85 FR 15798
(March 19, 2020). Under that rule
waiver, the Office of the Secretary will
accept only electronic filings at this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov). No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding electronic filing should
contact the Office of the Secretary,
Docket Services Division (202–205–
1802) or consult the Commission’s
Handbook on Filing Procedures.
Confidential Business Information:
Any submissions that contain
confidential business information must
also conform to the requirements of
section 201.6 of the Commission’s Rules
of Practice and Procedure (19 CFR
201.6). Section 201.6 of the rules
requires that the cover of the document
and the individual pages be clearly
marked as to whether they are the
‘‘confidential’’ or ‘‘nonconfidential’’
version, and that the confidential
business information is clearly
identified by means of brackets. All
written submissions, except for
confidential business information, will
be made available for inspection by
interested parties.
The Commission may include some or
all of the confidential business
information submitted in the course of
this investigation in the report it sends
to the USTR. Additionally, all
information, including confidential
business information, submitted in this
investigation may be disclosed to and
used: (i) By the Commission, its
employees and Offices, and contract
personnel (a) for developing or
maintaining the records of this or a
related proceeding, or (b) in internal
investigations, audits, reviews, and
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
evaluations relating to the programs,
personnel, and operations of the
Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government
employees and contract personnel (a)
for cybersecurity purposes or (b) in
monitoring user activity on U.S.
government classified networks. The
Commission will not otherwise disclose
any confidential business information in
a way that would reveal the operations
of the firm supplying the information.
Summaries of Written Submissions:
Persons wishing to have a summary of
their position included in the report
should include a summary with their
written submission and should mark the
summary as having been provided for
that purpose. The summary should be
clearly marked as ‘‘summary for
inclusion in the report’’ at the top of the
page. The summary may not exceed 500
words, should be in MS Word format or
a format that can be easily converted to
MS Word, and should not include any
confidential business information. The
summary will be published as provided
if it meets these requirements and is
germane to the subject matter of the
investigation. The Commission will list
the name of the organization furnishing
the summary and will include a link to
the Commission’s Electronic Document
Information System (EDIS) where the
full written submission can be found.
By order of the Commission.
Issued: May 26, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–11600 Filed 5–28–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–651]
Importer of Controlled Substances
Application: Agilent Technologies
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 29, 2020. Such persons
may also file a written request for a
hearing on the application on or before
June 29, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
DATES:
E:\FR\FM\29MYN1.SGM
29MYN1
Federal Register / Vol. 85, No. 104 / Friday, May 29, 2020 / Notices
reissuance to notify the public of the
expanded functionality of this system,
which now includes records of the
adjudications of Attorney Discipline
proceedings. This system will also
adopt new and modified routine uses to
better reflect the operational use of the
system.
DATES: In accordance with 5 U.S.C.
552a(e)(4) and (11), this notice is
effective upon publication, subject to a
30-day period in which to comment on
the routine uses, described below.
Please submit any comments by June 29,
2020.
ADDRESSES: The public, OMB, and
Congress are invited to submit any
comments to the United States
Department of Justice, Office of Privacy
and Civil Liberties, ATTN: Privacy
Analyst, 145 N Street NE, Suite 8W.300,
Washington, DC 20530, or by facsimile
at 202–307–0693 or by email at
Controlled
privacy.compliance@usdoj.gov. To
Drug code
Schedule
substance
ensure proper handling, please
reference the above CPCLO Order No.
Marihuana .............
7360
I
on your correspondence.
Tetrahydrocannabinols ....................
7370
I FOR FURTHER INFORMATION CONTACT:
Michelle Curry, EOIR Senior
Component Official for Privacy, EOIR
The company plans to import the
Office of the General Counsel, 5107
listed controlled substances in bulk
Leesburg Pike Suite 2600, Falls Church,
form for testing and calibration only.
The listed controlled substances are not VA 22041, or by phone at 703–305–
0990, or by email at michelle.curry@
for human or animal use. No other
usdoj.gov.
activities for these drug codes are
authorized for this registration.
SUPPLEMENTARY INFORMATION: To protect
the public, preserve the integrity of
William T. McDermott,
immigration proceedings and
Assistant Administrator.
adjudications, and maintain high
[FR Doc. 2020–11546 Filed 5–28–20; 8:45 am]
professional standards among
BILLING CODE 4410–09–P
immigration practitioners, EOIR
implemented the regulation,
‘‘Professional Conduct for
DEPARTMENT OF JUSTICE
Practitioners—Rules and Procedures,’’
[CPCLO Order No. 004–2020]
65 FR 39513 (June 27, 2000). EOIR
modified the rule in 2008 to increase the
Privacy Act of 1974; Systems of
number of grounds for discipline,
Records
improve the clarity and uniformity of
the rules, and incorporate miscellaneous
AGENCY: Executive Office for
technical and procedural changes. See
Immigration Review, United States
‘‘Professional Conduct for
Department of Justice.
Practitioners—Rules and Procedures,
ACTION: Notice of a modified system of
and Representation and Appearances,’’
records.
73 FR 76914 (Dec. 18, 2008). Effective
SUMMARY: Pursuant to the Privacy Act of January 18, 2017, the rules were again
1974, and Office of Management and
amended to extend discipline to
Budget (OMB) Circular No. A–108,
recognized organizations and to make
notice is hereby given that the Executive minor modifications to the
Office for Immigration Review
reinstatement process. See ‘‘Recognition
(hereinafter EOIR), a component within
of Organizations and Accreditation of
the United States Department of Justice
Non-Attorney Representatives,’’ 81 FR
(DOJ) or (Department), proposes to
92346 (Dec. 19, 2016). The term
update and reissue a current DOJ
‘‘practitioners’’ applies to attorneys and
System of Records, entitled EOIR–003
representatives who are authorized to
Practitioner Complaint-Disciplinary
represent aliens (but not attorneys
Files. EOIR–003 will be renamed,
representing the government) before
‘‘Attorney Discipline System.’’ The
EOIR’s immigration court and the Board
component proposes this update and
of Immigration Appeals (BIA or Board),
jbell on DSKJLSW7X2PROD with NOTICES
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 11, 2020, Agilent
Technologies, 250 Smith Street, North
Kingstown, Rhode Island 02852, applied
to be registered as an importer of the
following basic class(es) of controlled
substances:
VerDate Sep<11>2014
17:06 May 28, 2020
Jkt 250001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
32423
EOIR’s appellate component. The 2017
rule amendments have resulted in
revisions to the Attorney Discipline
System.
The EOIR Attorney Discipline
Program resides in the Office of the
General Counsel (OGC). Proceedings
created as a result of the Attorney
Discipline Program may include paper
and electronic files created by the
Disciplinary Counsel, who is the
program lead, attorneys supporting the
program, or program staff, and paper
and electronic adjudication files of the
BIA, the Office of Chief Immigration
Judge (OCIJ), and/or the Office of the
Chief Administrative Hearing Officer
(OCAHO). The new Attorney Discipline
System expands the prior system by
developing an electronic database that
contains information to track
complaints from receipt through final
disposition. The system is segregated by
need to know user controls and allows
authorized users to track various stages
of the proceedings. The system also
contains templates to generate letters,
notices, and decisions used in the
attorney discipline process. The system
can generate reports by case status and
disposition.
EOIR has applied routine uses to this
system. Having these routine uses
permits EOIR the necessary flexibility to
disclose information in ways that are
compatible with the purposes for which
the information was collected.
Specifically, EOIR has modified the
language in the routine uses in
paragraphs: 1–7; 9; 11 and 12 to
conform their language to the current
DOJ practice to describe the adopted
uses. These modifications do not
materially affect pre-existing routine
uses as they are merely stylistic
changes. EOIR has added a new routine
use 10 to inform the public that the
system and Attorney Discipline Program
may be supported by contractors,
grantees, experts, consultants, or
students who will access the system on
a need to know basis when necessary to
accomplish an agency function related
to this system of records. EOIR has also
added new routine use 13, to address
information release(s) in the event of a
suspected or confirmed breach of the
system, consistent with OMB guidance
to federal agencies (OMB Memorandum
17–12, Preparing for and Responding to
a Breach of Personally Identifiable
Information (PII)). Finally, EOIR has
added routine use 14 to allow release to
third-party entities or individuals to the
extent deemed necessary to elicit
information from them or their
cooperation to carry out authorized
activities of EOIR.
E:\FR\FM\29MYN1.SGM
29MYN1
]]>Agencies
[Federal Register Volume 85, Number 104 (Friday, May 29, 2020)]
[Notices]
[Pages 32422-32423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11546]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-651]
Importer of Controlled Substances Application: Agilent
Technologies
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 29, 2020.
Such persons may also file a written request for a hearing on the
application on or before June 29, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must
[[Page 32423]]
be sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152. All request for a
hearing should also be sent to: (1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement Administration, Attn: DEA Federal
Register Representative/DPW, 8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 11, 2020, Agilent Technologies, 250 Smith Street,
North Kingstown, Rhode Island 02852, applied to be registered as an
importer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana....................................... 7360 I
Tetrahydrocannabinols........................... 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk form for testing and calibration only. The listed controlled
substances are not for human or animal use. No other activities for
these drug codes are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-11546 Filed 5-28-20; 8:45 am]
BILLING CODE 4410-09-P
